(PRESS RELEASE) Vision Solutions Rx Inc, maker of virtual reality therapy solutions for multiple learning and cognitive disorders, and Xenon-VR , the first company to provide a true mobile, virtual reality medical grade headset designed  for the ophthalmic industry Inc jointly announce a new technology strategic technology sharing partnership. This collaboration will bring the next generation Diagnostic Medical equipment for screening, diagnostics, plus therapy.

Xenon-VR (XVR) is a medical device organization that has designed and is bringing to market next-generation eye diagnostic gear for use by Ophthalmologists, Optometrists, eye care Clinics, and other eye-care professionals.

The company Xenon-VR is a Delaware C-Corp. based in New Jersey. It is getting to marketplace the “Next-Generation of Eye Exams”, as early because Q1, 2023, in a compact, wearable head-set.

Xenon-VR’s first-generation products, called Xenon-1 (X-1) and Xenon-2(X-2), uses Artificial Intelligence, Machine Learning, patented Optics, a sophisticated Eye-Tracking System (ETS), and Liquid-Lens technologies – all integrated on the patented Virtual Reality Platform. Xenon-VR products are FDA registered X-1 and X-2 provide multiple eye exams in a headset plus function as different eye diagnostic equipment would in an eye doctor practice. Using a headset can provide more accurate and convenient ways for the doctor who may run a small practice to perform eye examinations. Our liquid lens technology replaces outdated hard lenses, provides faster refraction for eye care providers, plus leads to faster servicing of patients. Xenon-VR will be a comprehensive diagnostic examination whereas its competition offers only monitoring or testing functions. Xenon-VR offers 16+ exams including:

  • Visual Field Test: (10-2, 24-2, 24-2C, 30-2: (SITA, SITA-Fast, SITA-Faster) – Goldmann Standard – Medical Grade Device
  • Wavefront Refraction (ABT) & phoropter – With Objectives and Subjective.
  • Color Eyesight Extension Vision (D-15)
  • Visible Acuity (Near and Far Acuity)
  • Contrast | Low Contrast Visual Acuity
  • Pupillometry
  • Extraocular Motility
  • Vision Screeners
  • Binocular Humphrey Esterman Visible Fields (HEVF)

It is with great excitement in order to announce collaboration in the particular following manner to begin 2023 collectively.

  • VisionWEARx cognitive testing will be preloaded on all Xenon-1 (X-1) and Xenon-2(X-2) models simply by end associated with 2022 with an anticipated hardware sales with regard to 2023 of 1000 units
  • VisionWEARx will participate as a functional testing module for its cognitive tests in the large 10, 000 patient study in Kenya Africa to start Q1 2023
  • VisionWEARx will be rolled out along with the launch of 250 pre sold Xenon-2(X-2) models for January 2023 with SAAS and diagnostic revenues
  • Xenon-2(X-2) versions will be deployed to all clinical trials initiated by VisionWEARx partners 2022-2023 in cooperation
  • Both companies will work together inside the development of a virtual pen
  • Both companies will develop in collaboration a base unit VR headset cost effective plus robust to accommodate a screening and therapy model
  • Each companies look to collaborate on additional intellectual testing models such as PTSD, Autism, Asperger’s and Irlen Syndrome for 2023

From Zeshan Khan and Jeffrey Williamson: “This partnership will certainly be able to address issues plus problems from Dyslexia, dysphoria and Irlen syndrome to the eye treatment industry and with the Xenon-VR patented technology will be able to provide a true telehealth solution where doctors and patients are not in the same room but same time they are collecting plus diagnosis their patients remotely.


For Doctors and other eyecare professionals, they are usually able in order to reduce their own timeframe to see their particular patients distantly and able to see 5x more individuals at the same time they may be seeing one patient in traditional tabletop products.

This partnership will have the huge impact on eye care within the world, and the fact that Xenon-VR is not one and done but also capable to continuously improve the eyecare business with larger array associated with tests possible and more accurate compared to existing equipment.

“These new digital tools plus solutions may elevate individual interactions, gain practice efficiencies, increase capacity of insurance covered procedures at a time when there is usually intense pressure for staffing and throughput. ”

Leave a Reply

Your email address will not be published. Required fields are marked *